The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs

<strong>Background</strong> The available evidence on the benefits and harms of novel drugs and therapeutic biologics at the time of approval is reported in publicly available documents provided by the US Food and Drug Administration (FDA). We aimed to create a comprehensive database pro...

Bibliografske podrobnosti
Main Authors:	Ladanie, A, Speich, B, Naudet, F, Agarwal, A, Pereira, T, Sclafani, F, Martin-Liberal, J, Schmid, T, Ewald, H, Ioannidis, J, Bucher, H, Kasenda, B, Hemkens, L
Format:	Journal article
Izdano:	BioMed Central 2018

Podobne knjige/članki

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs
od: Aviv Ladanie, et al.
Izdano: (2018-09-01)

Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project
od: Matthias Briel, et al.
Izdano: (2019-11-01)

Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: meta-epidemiological analysis
od: Ewald, H, et al.
Izdano: (2018)

Current use and costs of electronic health records for clinical trial research: a descriptive study
od: Mc Cord, K, et al.
Izdano: (2019)

A scoping review shows that several nonvalidated budget planning tools for randomized trials are available
od: Speich, B, et al.
Izdano: (2019)

The Perception of Educational Software Development Self-Efficacy among Undergraduate CEIT Teacher Candidates
od: Adem Uzun, et al.
Izdano: (2013-08-01)

What proportion of ethically approved randomised clinical trials can be found in a trial registry?
od: Speich, B, et al.
Izdano: (2019)

Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study.
od: Kasenda, B, et al.
Izdano: (2020)

Treatments for subacute cough in primary care: systematic review and meta-analyses of randomised clinical trials
od: Speich, B, et al.
Izdano: (2018)

Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study
od: Benjamin Kasenda, et al.
Izdano: (2020-08-01)

Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data
od: Speich, B, et al.
Izdano: (2017)

Lung cancer screening in the gulf: Rationale and recommendations
od: Sami M Bennji, et al.
Izdano: (2022-01-01)

Lissi Rasmussen: Livshistorier og Kriminalitet. En empirisk undersøgelse af etnisk minoritetsunge i Københavns Fængsler, deres baggrund, status og fremtid. Hvilke kommunikationsmuligheder er der? Center for Europæisk Tænkning (CEIT), Det Teologiske Fakultet, Københavns Universitet, 2010, 236 sider. Bogen kan downloades gratis fra http://www.teol.ku.dk/afd/ceit//lissi_rasmussen _rapport
od: Stine Fehmerling
Izdano: (2010-09-01)

Single-dose versus 3-day cotrimoxazole prophylaxis in transurethral resection or greenlight laser vaporisation of the prostate: study protocol for a multicentre randomised placebo controlled non-inferiority trial (CITrUS trial)
od: Speich, B, et al.
Izdano: (2019)

Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies
od: Aviv, L, et al.
Izdano: (2019)

Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database
od: Julian Hirt, et al.
Izdano: (2023-06-01)

Characteristics and survival of patients with cancer with intended off-label use—a cohort study
od: Amanda Katherina Herbrand, et al.
Izdano: (2022-05-01)

Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation
od: Speich, B, et al.
Izdano: (2019)

Antioxidant Therapy in Cancer: Rationale and Progress
od: Maochao Luo, et al.
Izdano: (2022-06-01)

Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
od: Speich, B, et al.
Izdano: (2017)

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 1; peer review: 2 approved]
od: Perrine Janiaud, et al.
Izdano: (2020-10-01)

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days [version 2; peer review: 2 approved]
od: Perrine Janiaud, et al.
Izdano: (2020-10-01)

Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: The Adherence to SPIrit REcommendations (ASPIRE) study and associated projects
od: Gryaznov, D, et al.
Izdano: (2020)

Development of a Publicly Available, Comprehensive Database of Fiber and Health Outcomes: Rationale and Methods.
od: Kara A Livingston, et al.
Izdano: (2016-01-01)

Rationale for extent of operation choice in rectal cancer
od: R. Nikitenko, et al.
Izdano: (2021-11-01)

Rationale for MYC imaging and targeting in pancreatic cancer
od: Günter Schneider, et al.
Izdano: (2021-10-01)

Immunotherapy in endometrial cancer: rationale, practice and perspectives
od: Wenyu Cao, et al.
Izdano: (2021-06-01)

An open science pathway for drug marketing authorization-Registered drug approval.
od: Florian Naudet, et al.
Izdano: (2021-08-01)

An open science pathway for drug marketing authorization—Registered drug approval
od: Florian Naudet, et al.
Izdano: (2021-08-01)

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
od: De-Hua Yu, et al.
Izdano: (2020-08-01)

Shift work and cancer – considerations on rationale, mechanisms, and epidemiology
od: Giovanni Costa, et al.
Izdano: (2010-03-01)

Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy
od: Al B. Barqawi, et al.
Izdano: (2012-01-01)

ACCISS study rationale and design: activating collaborative cancer information service support for cervical cancer screening
od: Bullard Emily, et al.
Izdano: (2009-12-01)

Single-dose versus 3-day cotrimoxazole prophylaxis in transurethral resection or greenlight laser vaporisation of the prostate: study protocol for a multicentre randomised placebo controlled non-inferiority trial (CITrUS trial)
od: Benjamin Speich, et al.
Izdano: (2019-02-01)

Availability of patient-centered cancer support services: A statewide survey of cancer centers.
od: Kathleen B Cartmell, et al.
Izdano: (2018-01-01)

Rationale for repeat breast-conserving surgery after in-breast recurrence of breast cancer
od: V. A. Uimanov, et al.
Izdano: (2014-07-01)

Application of Autofluorescence Endoscopy for Colorectal Cancer Screening: Rationale and an Update
od: Hiroyuki Aihara, et al.
Izdano: (2012-01-01)

Virtual reality for management of cancer pain: Study rationale and design
od: Hunter Groninger, et al.
Izdano: (2022-04-01)

Toward Maximizing Immunotherapy in Metastatic Castration Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy
od: Susan F Slovin
Izdano: (2012-05-01)

Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancer
od: R. M. Paltuev
Izdano: (2020-03-01)